Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Adult Gynecological Tumors

Interventions

BIOLOGICAL

Autologous tumor infiltrating lymphocyte injection（GT201）

GT201 treatment for advanced gynecological tumors (advanced cervical cancer)

Trial Locations (1)

RECRUITING

Shanghai Jiaotong University School of Medcine, Renji Hospital Ethica Committee, Shanghai